Skip to contentR
Repligen Corp
R
RGENRepligen Corp Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$197.91M$197.91Mderived+18.1% vs Q4 2024 Net Income$13.29M$13.29MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Repligen Corp · CIK 730272 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$17,868,000N/M Operating Cash Flowderived$25,704,000−34.4% Free Cash Flowderived$17,551,000−47.8% Margins · derivedOperating margin9.0%+30.8 pt vs Q4 2024
Net margin6.7%+26.9 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 26, 2026 · 57 d after period end